These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33665625)

  • 1. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.
    Gamboa CM; Jara K; Pamarthy S; Liu L; Aiken R; Xiong Z; Danish S; Sabaawy HE
    STAR Protoc; 2021 Mar; 2(1):100345. PubMed ID: 33665625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
    Golebiewska A; Hau AC; Oudin A; Stieber D; Yabo YA; Baus V; Barthelemy V; Klein E; Bougnaud S; Keunen O; Wantz M; Michelucci A; Neirinckx V; Muller A; Kaoma T; Nazarov PV; Azuaje F; De Falco A; Flies B; Richart L; Poovathingal S; Arns T; Grzyb K; Mock A; Herold-Mende C; Steino A; Brown D; May P; Miletic H; Malta TM; Noushmehr H; Kwon YJ; Jahn W; Klink B; Tanner G; Stead LF; Mittelbronn M; Skupin A; Hertel F; Bjerkvig R; Niclou SP
    Acta Neuropathol; 2020 Dec; 140(6):919-949. PubMed ID: 33009951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors.
    Oudin A; Baus V; Barthelemy V; Fabian C; Klein E; Dieterle M; Wantz M; Hau AC; Dording C; Bernard A; Michelucci A; Yabo YA; Kanli G; Keunen O; Bjerkvig R; Niclou SP; Golebiewska A
    STAR Protoc; 2021 Jun; 2(2):100534. PubMed ID: 34027491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma Model Using Human Cerebral Organoids.
    Ogawa J; Pao GM; Shokhirev MN; Verma IM
    Cell Rep; 2018 Apr; 23(4):1220-1229. PubMed ID: 29694897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthotopic Patient-Derived Glioblastoma Xenografts in Mice.
    Xu Z; Kader M; Sen R; Placantonakis DG
    Methods Mol Biol; 2018; 1741():183-190. PubMed ID: 29392700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion.
    Darrigues E; Zhao EH; De Loose A; Lee MP; Borrelli MJ; Eoff RL; Galileo DS; Penthala NR; Crooks PA; Rodriguez A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
    Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
    BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.
    McNeill RS; Canoutas DA; Stuhlmiller TJ; Dhruv HD; Irvin DM; Bash RE; Angus SP; Herring LE; Simon JM; Skinner KR; Limas JC; Chen X; Schmid RS; Siegel MB; Van Swearingen AED; Hadler MJ; Sulman EP; Sarkaria JN; Anders CK; Graves LM; Berens ME; Johnson GL; Miller CR
    Neuro Oncol; 2017 Oct; 19(11):1469-1480. PubMed ID: 28379424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
    Lago C; Federico A; Leva G; Mack NL; Schwalm B; Ballabio C; Gianesello M; Abballe L; Giovannoni I; Reddel S; Rossi S; Leone N; Carai A; Mastronuzzi A; Bisio A; Soldano A; Quintarelli C; Locatelli F; Kool M; Miele E; Tiberi L
    EMBO Mol Med; 2023 Dec; 15(12):e18199. PubMed ID: 38037472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
    Xiao W; Zhang R; Sohrabi A; Ehsanipour A; Sun S; Liang J; Walthers CM; Ta L; Nathanson DA; Seidlits SK
    Cancer Res; 2018 Mar; 78(5):1358-1370. PubMed ID: 29282221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA-AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models.
    Jandial R; Neman J; Lim PP; Tamae D; Kowolik CM; Wuenschell GE; Shuck SC; Ciminera AK; De Jesus LR; Ouyang C; Chen MY; Termini J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain Barrier.
    Kim M; Ma DJ; Calligaris D; Zhang S; Feathers RW; Vaubel RA; Meaux I; Mladek AC; Parrish KE; Jin F; Barriere C; Debussche L; Watters J; Tian S; Decker PA; Eckel-Passow JE; Kitange GJ; Johnson AJ; Parney IF; Anastasiadis PZ; Agar NYR; Elmquist WF; Sarkaria JN
    Mol Cancer Ther; 2018 Sep; 17(9):1893-1901. PubMed ID: 29970480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies.
    Kerstetter-Fogle AE; Harris PLR; Brady-Kalnay SM; Sloan AE
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an orthotopic glioblastoma mouse model for preclinical studies.
    Iturrioz-Rodríguez N; Piccardi F; Bertorelli R; Ciofani G
    Methods Cell Biol; 2024; 185():49-65. PubMed ID: 38556451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts.
    Koessinger AL; Koessinger D; Stevenson K; Cloix C; Mitchell L; Nixon C; Gomez-Roman N; Chalmers AJ; Norman JC; Tait SWG
    Sci Rep; 2020 Sep; 10(1):15361. PubMed ID: 32958777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of experimental compounds in orthotopic brain tumor mouse models.
    Eyme KM; Carvalho L; Badr CE
    STAR Protoc; 2021 Mar; 2(1):100290. PubMed ID: 33532737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effect of Cabazitaxel and Blood-Brain Barrier opening in a Patient-Derived Glioblastoma Model.
    Sulheim E; Mørch Y; Snipstad S; Borgos SE; Miletic H; Bjerkvig R; Davies CL; Åslund AKO
    Nanotheranostics; 2019; 3(1):103-112. PubMed ID: 30899638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts.
    Almstedt E; Rosén E; Gloger M; Stockgard R; Hekmati N; Koltowska K; Krona C; Nelander S
    Neuro Oncol; 2022 May; 24(5):726-738. PubMed ID: 34919147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered cerebral organoids model brain tumor formation.
    Bian S; Repic M; Guo Z; Kavirayani A; Burkard T; Bagley JA; Krauditsch C; Knoblich JA
    Nat Methods; 2018 Aug; 15(8):631-639. PubMed ID: 30038414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.